229K Seniors Got Heart Procedures They Didn’t Need? (Outrageous)

Chest pain sends most of us straight into panic mode.

And when a doctor says, “You need a stent,” few patients think to ask questions.

They assume it’s lifesaving.

Urgent.

Non-negotiable.

But new Medicare data reveals a disturbing truth – and you need to know about it before ever agreeing to a stent.

Once every seven minutes, a Medicare patient undergoes an unnecessary heart stent.

Let that sink in.

In fact, a Lown Institute investigation found that over a three-year period, more than 229,000 seniors received coronary stents they likely did not need.

That’s roughly 1 in every 5 stents placed—procedures that failed to:

• improve survival
• prevent heart attacks
• or meaningfully change outcomes for patients with stableheart disease.

Stents absolutely save lives during acute heart attacks, when an artery is suddenly blocked.

But for stable coronary artery disease—the kind most seniors have—decades of research show something shocking:

Stents do not reduce the risk of future heart attacks or death compared to medication, diet changes, and lifestyle intervention alone.

In other words, many patients go through an invasive heart procedure…

With no added survival benefit.

And the risks are real.

• Blood clots
• Artery damage
• Bleeding
• Repeat procedures
• Even death

All for a treatment that often doesn’t outperform pills and lifestyle changes.

So why does overuse continue? Because the system rewards procedures—not patience.

Medicare data shows enormous variation between hospitals.

Some facilities place unnecessary stents in 40–50% of patients.

Others keep rates as low as 1–4%.

That gap doesn’t come from patient differences. It comes from hospital culture, financial incentives, and institutional habits.

Stents are profitable. They’re fast. They fit neatly into catheterization lab workflows.

And once a hospital builds its system around them, restraint becomes the hardest thing to practice.

As one expert put it, overuse persists not because of bad doctors—but because good doctors are trapped inside bad systems.

And the financial cost is staggering.

Unnecessary stents drained up to $2.4 billion from Medicare in just three years.

That’s taxpayer money. YOUR money.

And unlike a prescription that can be stopped, a stent is permanent. Once it’s in, there’s no undo button.

If a stent is recommended—and you’re not actively having a heart attack—slow down.

Ask:

• Is this an emergency, or is my condition stable?
• What happens if we try medication and lifestyle changes first?
• Can I get a second opinion from a non-procedural cardiologist?

For stable heart disease, blood pressure control, diet, and exercise often deliver the same outcomes without the risks of an invasive procedure.

And a major clinical trial found that Coenzyme Q10 supplementation reduced death from heart disease by nearly half and improved quality of life in chronic heart failure patients—without the risks of surgery or stents.

Safe, low-cost, and effective, this is one example of a non-invasive strategy seniors can discuss with their cardiologists.

Luma Nutrition offers a 400mg supplement with rave reviews. https://lumanutrition.com

Knowledge doesn’t just protect your wallet.

It protects your heart.

Because the most dangerous assumption a patient can make is that more intervention always means better care.

Sometimes, the smartest medicine is knowing when not to intervene.

To protecting your heart,

Ray Thatcher
Research Director, Health Sciences Institute

Sources:

• Lown Institute. (2023). Avoiding coronary stent overuse. Lown Hospitals Index. https://lownhospitalsindex.org/avoiding-coronary-stent-overuse/
• Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., … & COURAGE Trial Study Group. (2007). Optimal medical therapy with or without PCI for stable coronary disease. New England Journal of Medicine, 356(15), 1503–1516. https://doi.org/10.1056/NEJMoa070829
• Mortensen, S, Rosenfeldt, F, Kumar, A. et al. The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure: Results From Q-SYMBIO: A Randomized Double-Blind Trial. J Am Coll Cardiol HF. 2014 Dec, 2 (6) 641–649. https://doi.org/10.1016/j.jchf.2014.06.008